swissstocks

4 Comments

ON: Mon Apr 21st 09:58 AM
Commented on:
Starting Monday: Big Pharma Reports This Week

Swiss Analysts Reactions to Novartis Q1 Earnings:
* ZKB keeps Market Perform
* Helvea keeps Acumulate, Price Target CHF75
* Vontobel keeps Buy, Price Target CHF68
* Credit Suisse keeps Underperform, New Price Target CHF49
* Keppler keeps Reduce, Price Target CHF70 (funny in my opinion ?!?!?)
View article »
ON: Wed Apr 2nd 07:10 AM
Commented on:
Stocks Rally on Financial Writedowns: Overly Optimistic?

It is sadly true that investors are no more so much impressed by write-downs and consider them as "normal" (as when it was "normal" to value Internet companies by the number of visitors...) I think we should expect more write-downs and perhaps anohter capital increase from UBS this year. These guys just don't seem to be able to evaluate their exact financial situation.
View article »
ON: Tue Apr 1st 02:44 AM
Commented on:
Oppenheimer’s Whitney Cuts U.S. Bank Estimates - Again

Good forecast for UBS witth the huge write-down announced this morning ;o(
View article »
ON: Tue Apr 1st 02:40 AM
Commented on:
A Look at Bank and Broker Default Risk

I suppose that UBS will be higher in the ranking after this morning annoucement. The problem for the whole industry remains in the lack of visility... about their true current situation
View article »

Symbols:

Authors:

More Transcripts»

Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »

Employers: See all recruitment options, get applications online or by email Post a job »